could induce not only T2DM-like metabolic disorders but also AD-like neuropsychiatric behavior in mice, as indicated by the increased blood glucose levels and serum insulin levels and the impaired cognitive ability in NOR, Y-maze, and MWM tests. This evidence concerns the gene INS and metabolic disease.